期刊名称：EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
About the Journal
Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research in this new, yet ancient world of complementary and alternative medicine.
The Journal seeks to apply scientific rigor to the study of complementary and alternative medicine (CAM) modalities, particularly traditional Asian healing systems. eCAM emphasizes health outcome, while documenting biological mechanisms of action. The journal is devoted to the advancement of science in the field of basic research, clinical studies, methodology or scientific theory in diverse areas of Biomedical Sciences.
Open Access to All eCAM Papers Online
OUP has adopted a policy of 'Open Access' for all eCAM papers online. So, regardless of where you are geographically based, you will be able to read all published research in eCAM at no cost to yourself, and without a subscription. Furthermore publishing authors will not be required to pay an author submission charge for eCAM -- often a common requirement for other Open Access journals. This has been made possible by the generous support of Hokuriku University and Ishikawa Natural Medicinal Products Research Center (INMPRC).
Abstracting and Indexing Services
Abstracts and citations for Evidence-based Complementary and Alternative Medicine are available via PubMed. The ful
Instructions to Authors
Instructions for Authors
Scope of the Journal
Evidence-based Complementary and Alternative Medicine (eCAM) is an international rigorously peer-reviewed journal, devoted to the advancement of science in the field of complementary and alternative medicine by providing an international forum for collaboration and debate. As the title states, our aim is to evaluate non-conventional or non-modern Western medicine and therapies by modern scientific methods to establish standards in this emerging, chaotic field. Only manuscripts of the highest scientific quality, that are concisely written and that comply with these Instructions for Authors will be accepted.
The journal Evidence-based CAM publishes articles on basic and clinical research, methodology, and history and philosophy of medicine in relevant areas. It will include the following areas in biomedical sciences: phytotherapy (herbal medicine), Ayurvedic medicine, traditional Chinese medicine (TCM), Kampo medicine, homeopathy, acupuncture/acupressure, hydrotherapy (balneology), relevant animal molecules (RAMS), and neuroimmune mechanisms (NIMS). New sources of natural plant and animal molecules will also be considered.
Publication Policies
Evidence-based CAM will focus on the evidence basis of CAM. In basic research, the Journal will publish articles that shed new light on interesting biological mechanisms by which those non-conventional remedies exert their effects. Research on immunological and neuropsychological aspects will be given high priority. The Journal welcomes studies on herbal and animal products, identification of the active ingredients, their mechanisms of action, combinatorial studies, and quality control and quality assurance. In clinical research, Evidence-based CAM will give priority to articles that have been designed and that have used standard methodology of evidence-based medicine. These will include retrospective and prospective studies with matched controls, placebos, randomized trials, comparisons with existing protocols and pharmaceuticals for treatment, and different phases of clinical trials.
At the same time, the Journal is open to any novel ideas and unorthodox approaches, as long as they provide evidence that can be critically evaluated. Especially welcomed is research from the viewpoint of complex systems, where new methodology is yet to be established.
Contributions should be prepared as original articles or reviews according to these Instructions for Authors. Editorials, Commentaries and lecture series will be commissioned. Material offered for publication must be original, unpublished and not under simultaneous consideration by another journal. Any previous publication of the material (including conference proceedings, letters to journals and brief communications) must be declared. The posting of essentially raw data on a Web site without significant analysis is not considered to represent prior publication.
Ethics
In reports of investigations using humans or animals, authors should indicate their adherence to ethical standards and may note the approval of an ethics or animal research committee when this is relevant. Patients must not be referred to by their own initials or hospital numbers. Work offered for publication in the Journal must conform to the standards for experimentation and care set down in the Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects by the World Medical Association (http://www.wma.net/e/policy/b3.htm).
Animal experiments should refer to the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes and its appendix and/or the National Research Council Guide for the Care and Use of Laboratory Animals (http://www.nap.edu/readingroom/books/labrats/index.html) as guidelines. If experimental methodology raises particular ethical or welfare concerns, they will be judged by the Editorial Office using current UK legislation Animals (Scientific Procedures) Act 1986 for additional guidance.
Reports on herbal and animal products will follow the ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for human use) guidelines, preclinical evaluations encompassing animal models, in vitro studies, toxicity and safety evaluations, dosimetry, efficacy assessments, and clinical investigations.
Authors in doubt about complying with these provisions should contact the Editorial Office.
Conflict of Interest
At the point of submission, eCAMl鈥檚 policy requires that each author reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?
As an integral part of the online submission process, Corresponding authors are required to confirm whether they or their co-authors have any conflicts of interest to declare, and to provide details of these. If the Corresponding author is unable to confirm this information on behalf of all co-authors, the authors in question will then be required to submit a completed Conflict of Interest form to the Editorial Office. It is the Corresponding author鈥檚 responsibility to ensure that all authors adhere to this policy.
If the manuscript is published, Conflict of Interest information will be communicated in a statement in the published paper.
Peer review
OUP Journals has a strict policy regarding conflicts of interest arising in the course of the peer review process. Editors and reviewers who discover that they have a conflict of interest in relation to any submitted article must absolve themselves from any commitments and may not be involved in any part of the peer review process for that article.
Conflicts of interest can occur through the existence of personal, professional or financial relationships between the Editor or reviewer and the author, the author's institution or sponsor. Involvement in competing projects can also produce conflicts of interest.
Reviewers are required to report any potential conflict of interest to the Editor and Editors are required to report regularly to OUP about potential conflicts of interest involving the journal staff. Both Editors and reviewers agree to keep the contents of any articles confidential and not to make any use of information or material which they become aware of during the peer review process.
If the article is published, such information may be communicated in a note following the text and references.
Authorship
As the representative of the authors, the corresponding author must ensure that all authors are given access to submitted and revised versions of manuscripts. The corresponding author is responsible for the collation of the authors signatures on submission letters and also the collation and communication of proof corrections to the Journal. The corresponding author should be the signatory of the license to publish form. As the authors' nominated representative, the corresponding author will be held primarily accountable for any failure to comply with these Instructions for Authors or generally accepted standards of good practice. This does not absolve other authors of responsibility, however.
The corresponding author will act as the primary contact for correspondence regarding the manuscript, and as such, authors should take care not to appoint a corresponding author likely to be absent for extended periods (such as on a sabbatical) while the manuscript is being reviewed and prepared for publication as this is likely to cause unacceptable delays.
Copyright
It is a condition of publication in Evidence-based CAM that authors grant an exclusive license to Oxford University Press. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently, and will also allow the article to be as widely disseminated as possible. As part of the license agreement, authors may use their own material in other publications provided that Evidence-based CAM is acknowledged as the original place of publication and that Oxford University Press is notified in advance in writing.
Types of Articles Published
Original Articles: Original articles should include new findings in the areas covered by the Journal. Methods and data used should be clarified, and evidence must be critically evaluated. An original article should not much exceed 5000 words, and should include an Abstract, Introduction, Subjects and Methods, Results, Discussion and References, in that order.
Reviews: The Journal accepts reviews that deal with a particular theme or area of study in a thoughtful and exhaustive manner. A review should not much exceed 8000 words.
Hypotheses, Conjectures, Comments: Evidence-based CAM will publish in the section Hypotheses-Conjectures-Comments papers proposing hypotheses that are interesting but still lack certain evidence. The paper can be purely speculative, but authors are requested to thoroughly discuss existing data related to the hypothesis and also to propose a methodology (experimental, epidemiological or statistical) as to how the hypothesis can be tested. Authors can include figures and illustrative models that enhance the paper and that are considered essential. For any paper accepted in this section, the Journal will publish 'Comments' at the same time. An Editorial Board member will usually write the 'Comments'. A paper submitted for this section should not exceed 5000 words.
Commentaries and Lecture Series: The journal publishes Commentaries and Lecture Series on a commission basis. Their content and format are discussed and decided between the author and Editor-in-Chief. Prospective authors who wish to contribute to these sections are welcomed to contact the Editor-in-Chief, the Editorial Office, or any Board members
Case Reports: Only case reports with high importance and quality will be published.
Online Submission and Refereeing System
Evidence-based CAM will receive submissions through its online submission and reviewing system. Prospective authors should access http://ecam.manuscriptcentral.com to submit manuscripts.
The Submission Instructions should be reviewed before submitting a manuscript to eCAM.
Processing of manuscripts
After preliminary examination of a submitted manuscript by the Editorial Office staff to check that all the necessary elements are present, the manuscript is passed to the Editor-in-Chief and Managing Editor. Submitted manuscripts will be assigned to at least two reviewers for evaluation. The Editor-in-Chief or Managing Editor may ask authors for revisions. Revised manuscripts should be resubmitted within three months. A final decision on publication made by the Editor-in-Chief will be transmitted by the Managing Editor to the author through the Editorial Office.
Article format Manuscripts should be written in clear and concise, grammatical English. A contributor whose native language is not English is recommended to have the manuscript checked by a native speaker of English. The Editor-in-Chief and Managing Editor will not assume the responsibility of making extensive revisions so that manuscripts are clear for referees.
All documents should be double-spaced. A clear, legible single font (Times/Times New Roman, Helvetica/Arial preferred) and point size of 11 should be used throughout. All submitted manuscripts should be page numbered.
In original articles and reviews, authors should submit three to five keywords that do not occur in the title of the article. Very general terms like "bacteria" and terms already present in the title should be avoided, as should nonstandard abbreviations.
Title page The title page should carry a) the title of the article; b) authors names with institutional affiliations; c) corresponding authors name with phone and fax numbers and E-mail address; e) a running head of no more than 50 characters including spaces.
Abstract The second page should carry an abstract of no more than 250 words.
References Number references consecutively in the order in which they are first mentioned in the text. The titles of journals should be abbreviated according to the style used in Index Medicus.
List all authors, but if the number exceeds six, give names of six followed by "et al." All references should be available in English and must be current. When citation of articles written in languages other than English is unavoidable, enter the language in parenthesis at the end of the reference.
Article: 1. White A, Hayhoe S, Hart A, Ernst E. Adverse events following acupuncture: prospective survey of 32 000 consultations with doctors and physiotherapists. Br Med J 2001;323:485-486.
Book: 2. Butler K, Barrett S. Consumer's Guide to Alternative Medicine: A Close Look at Homeopathy, Acupuncture, Faith Healing, and Other Unconventional Treatments. Buffalo: Prometheus Books 1992.
Chapter within a book: 3. Filshie J, Cummings TM. Western medical acupuncture. In: Ernst E, White A, editors. Acupuncture: A Scientific Appraisal. Oxford: Butterworth Heinemann: 1999, 31-59.
Tables Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Place explanatory matters in footnotes, not in the heading. Explain in footnotes all nonstandard abbreviations that are used in each table.
Figures Figures should be professionally drawn and photographed. Letters, numbers and symbols should be clear, consistent throughout, and large enough that when reduced for publication each item will still be legible. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend.
Color photographs will principally be published with the full cost borne by the authors (350 GBP). Manuscripts submitted with color photographs will be reviewed on the assumption that the authors will cover the publication cost if accepted.
Supplementary data Files containing supplementary data (for example large tables or a questionnaire) will be linked with the article published online as an extra resource for readers. Please contact the Editorial Office for further details.
Abbreviations (and nomenclature) Nonstandard nomenclature and abbreviations should be defined at the first occurrence. Introduce abbreviations only where multiple use is made.
Statistics The methods of statistical analysis should be described in sufficient detail. The word "significant" should be used only if a result is statistically significant and where exact P values are given. In clinical articles, outcome variables should be given as point estimates, with 95% confidence intervals rather than standard deviations or standard errors.
Assignment of copyright Manuscripts are considered on the understanding that after acceptance and before publication the authors will grant an exclusive license to publish to Oxford University Press.
Proofs
Proofs are sent to the corresponding author by e-mail as a PDF. These should be read carefully, paying particular attention to any tables, figures and references, and then corrected and returned to the Production Editor by fax (+44 1865 353 798) or email within three business days of receipt. Authors should pay particular attention that they check any dosage directions, owing to the seriousness of any error entering the printed record. Extensive changes at the proof stage are not permitted. Authors may be charged for correction of their non-typographical errors. In the event of important developments in a field that affect the manuscript arising after the final revision, a 'Note added in proof' may be permitted.
Offprints
The corresponding author will be sent free electronic access to their article. An offprint order form will be sent to the corresponding author with the proofs for ordering of additional offprints.
Submitting Your Manuscript
If you are ready to submit your manuscript, please follow the the eCAM Submission Instructions.
Clinical Papers
1. Brief case reports;
2. Developed case reports with detailed, illustrative documentation;
3. Case reports expanded into hypotheses;
4. Clinical studies with as strong an evidence base as possible.
1. Brief Case Reports
The brief case reports describe, in 600 words, a single interesting case. The main criterion for selection of a case is that it should address a significant question in the CAM community or enable readers to learn something. Case reports can be but do not have to be reports of rare conditions. They can report unusual presentations of more common conditions, challenging differential diagnoses, mistaken diagnoses, novel or uncommon methods of treatment or unexpected outcomes. Preferably the case should have a good illustration. Consent for publication in print and electronically must be obtained from the patient or, if this is not possible, the next of kin. (See Patients' consent and permission to publish).
2. Developed case reports with detailed, illustrative documentation;
These detailed case reports are from 1,500 to 2,000 words. They may be longer, up to 5,000 words, if a series of cases is reported or if there is a demonstrable need for a long introduction to review the literature. These reports should be accompanied by illustrative figures. eCAM鈥檚 preference is for brief case reports and the longer ones will go through a strict review by the editorial office before deemed worthy to enter the review system.
3. Case reports expanded into hypotheses;
These case reports are from 1,500 to 2,000 words or up to 5,000 words if describing a series of cases. The case or cases should be strictly analyzed and a hypothesis developed.
4. Clinical studies with as strong an evidence base as possible.
Clinical studies should be submitted in the form of Original Articles. Authors should note that the journal place importance on evidence. It is preferred that rondomized-controled studies with double-blinded procedures are performed. If the nature of the study does not allow such study design, authors should give thorough explanation as to why this is not possible, and how they have handled the problem to minimize bias.
Special Instructions for Clinical Paper Submission:
Title
The title can be up to 20 words and should include the name of the condition reported. If it is appropriate, the title can signal the message conveyed by the report, for example, 鈥楳istaken diagnosis of ...鈥� or 鈥楢n unusual presentation of ...鈥� or 鈥楶iggy-back contact lenses can work in correcting ...鈥�. Please refrain from the use of the word 鈥淓ffects鈥�. Rather, express what the effect is.
Abstract
The abstract should be fewer than 275 words and have a structured format with the following subheadings: Introduction, Methods, Results and Discussion. A further section, Conclusions, can be added.
Introduction
The introduction should set the scene by describing some of what is known about the condition reported to provide the basis for understanding the aspects of the case reported that are different or interesting. The introduction does not need to be a major and comprehensive review of the condition. Authors must refer to recent literature to enable readers of their case report to understand the special aspects of the case.
Literature
We expect authors to refer to literature of the topic of the study. They should be recent (in the past 10 or 15 years), and preferably should be written in English. Liberature can be found at:
Entrez PubMed www.ncbi.nlm.nih.gov/entrez/query.fcgi
eCAM papers are found at http://ecam.oxfordjournals.org/
The Case
A description of the case follows the introduction. This should include all the clinical information that is relevant to understanding the case reported. Do not report clinical information that is not relevant to the story. The description usually will be an unfolding chronological account of the clinical findings and management, beginning with the author鈥檚 findings at the first visit. For example, 鈥楢 white male patient aged 49 years came because of difficulty reading over the previous six months. He also complained of On examination it was found 鈥︹��.
Discussion and Conclusions
The discussion will consider the special aspects of the case. It may discuss how the case is similar to or differs from typical cases described in recent literature. It may comment on whether similar findings have been reported by others. It may discuss other diagnoses that were possible and the reasons for the diagnosis that was reached. It may warn about the risks of misdiagnosis. It may draw attention to the value of the management strategies followed in this case and how they differ from the usual strategies. Statements of facts or of the opinions of others will be supported by references. The discussion will make the learning message clear. For example, 鈥楾his case shows how important it is to ...鈥� or 鈥楾his case shows that in selected cases it is possible to provide considerable improvement of vision by 鈥︹��. If there are several conclusions or if the conclusion needs a lengthy explanation, there can be a separate conclusions section after the discussion.
Illustrations
Case reports usually have one or more illustrations. These can be clinical photographs, radiographs or visual field charts or whatever is necessary to make the points of the case report clear. Include only those illustrations that add information and are necessary to tell your story. Clinical photographs can be submitted as prints in color or black and white, or in electronic form. Illustrations submitted in electronic form must have a minimum resolution of 300 dpi. They must be supplied as separate files. Use a separate file for each electronic image. Do NOT embed illustrations in the Word document carrying your text. Electronic files can be supplied in any of the following formats: Encapsulated Post Script (eps), Tagged Image File Format (tif or tiff) or JPEG (jpg). Label electronic files clearly, showing author name, figure number and format. For example: BrownFigure2.tif.
References
References should be listed at the end of the text in the format described in the 鈥業nstructions for authors鈥� published on the journal鈥檚 internet site: www.ecam.oupjournals.org.
Patent Confidentiality and Consent
The identity of patients who are subjects of case reports must be protected. Any identifying names or initials on photographs or visual field charts must be removed or obscured and nothing in the text should enable the patient to be identified. Written patient consent must be obtained if a photograph of the face or any part of the face of the patient is in any photograph. Authors must certify in writing that they hold written patient consent to publish if the patient is in any way able to be identified through the photographs or otherwise.
Funding
Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgements' section [update as appropriate]. The following rules should be followed: the full official funding agency name should be given, i.e. 鈥楴ational Institutes of Health鈥�, not 鈥楴IH鈥�; grant numbers should be given in brackets; multiple grant numbers should be separated by a comma; agencies should be separated by a semi-colon; no extra wording like 'Funding for this work was provided by ...' should be used; where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'. An example is given here: 鈥楴ational Institutes of Health (CB5453961 to C.S., DB645473 to M.H.); Funding Agency (hfygr667789).鈥�
Editorial Board
Editorial Board
Professor Tomio Tada Honorary Founder Emeritus: JAPAN, Immunology
Professor Edwin L. Cooper Founding Editor in Chief: USA, Comparative Immunology; Invertebrate Immunobiology, Evolution of Neuroimmune Systems; Member: Brain Research Institute; Psychoneuroimmunology Program; Jonsson Cancer Center, UCLA
Professor Nobuo Yamaguchi Founding Managing Editor: Department of Fundamental Research for CAM, Kanazawa Medical University, Uchinada, Ishikawa, 920-0293, Japan.
Susumu Kawashima Managing Editor and President: Hokuriku University, Japan
Patty Christiena Willis Founding International Administrator: USA, JAPAN
(In Alphabetical Order with Disciplines)
Toru Abo, MD (JAPAN) Immunology and Paracytology
Paolo Bellavite (ITALY) Homeopathy
Joao B. Calixto (BRAZIL) Pharmacology of Natural Products
Catherine Carpenter (USA) Epidemiology
Piu Chan (CHINA) Geriatric Medicine, Neurology
Il-Moo Chang (KOREA) Herbal Medicine
Chieh-Fu Chen, (TAIWAN) Pharmacology, Biochemistry
Juei-Tang Cheng (TAIWAN) Pharmacology, Biochemistry
Francesco Chiappelli (USA) Evidence-Based CAM
Andrea Cossarizza (ITALY) Immunology
Yoshito Eizuru (Japan) Virology
Elaine Elisabetsky (BRAZIL) Pharmacology
Rashika El Ridi (EGYPT) Immunology of Parasitic Diseases
Edzard Ernst (U.K.) Complementary Medicine
Claudio Franceschi, (ITALY) Immunology
Gerhard Franz, (GERMANY) Pharmaceutical Science; Phytotherapy
Carlo Maria Giovanardi (ITALY) Acupuncture
Michael Goldstein (USA) Sociology
Yeong L.Ha (KOREA) Drug Development
Ji-Sheng Han (CHINA) Acupuncture
Alex Hankey (U.K.) Ayurvedic and Mind-Body Medicine and Biological Regulation
Mary L. Hardy (USA) Integrative Medicine; Botanicals; Evidence Based CAM
David Heber (USA) Phytochemicals; Botanical Dietary Supplements
Peter Houghton (U.K.) Pharmacognosy
Ka-Kit Hui (USA) East-West Medicine
Jiro Imanishi (JAPAN) Microbiology; Aromatherapy
Masaki Inoue (JAPAN) Molecular Reproductive Biology
Michael Irwin (USA) Psychoneuroimmunology; Mind-body interventions
Masamitsu Ishii (JAPAN) Dermatology
Krishna Kaphle (NEPAL) Veterinary Science, Chinese Traditional Medicine
Ted Jack Kaptchuk (USA) Placebo effect
Shinji Kasahara (USA, JAPAN) Comparative Neuroimmunology; Psychoneuroimmunology
Yeong Shik Kim (KOREA) Evidence-based Korean Medicine
Hiromi Kobayashi (JAPAN) Dermatology
Wolfgang Koenig (GERMANY) Cardiology
Byung Hee Koh (KOREA) Korean Medicine
Hye-Jung Lee (KOREA) Acupuncture
George Lewith (U.K.) Complementary Medical Physician
Sabina Lim (KOREA) Acupuncture, Korean medicine
Jen-Kun Lin (TAIWAN) Pharmacology, Biochemistry
Ulrike Lindequist (GERMANY) Pharmaceutical Biology
Sheng-Xing Ma (USA) Acupuncture
Francesco Marotta (ITALY) Hepato-Gastroenterology, Nutraceuticals
Yoshinori Marunaka (JAPAN) Renal and Lung diseases, Hypertension
Emeran Mayer (USA) Digestive Diseases, Behavioral Physiology
Emilio Minelli (ITALY) Acupuncture; Homeopathy; Phytotherapy; Integrative Medicine
Yasuhide Mitsumoto (JAPAN) Experimental Neurology and Therapeutics
Werner Mueller (GERMANY) Evochemistry; Bioactive Compounds
Tsugiya Murayama (JAPAN) Virology
Bruce Naliboff (USA) Digestive Diseases; Psychophysiology
Tsutomu Ogura (JAPAN) Cancer Research and Molecular Biology
Ko Okumura (JAPAN) Immunology
Richard Pietras (USA) Integrative Oncology
P. Pushpangadan (INDIA) Ethnopharmacology
Jose Olalde Rangel (VENEZUELA) Adaptogenic medicine
M.H. Ravindranath (USA) Cancer Immunology and Glycoimmunotherapy
Paolo Roberti di Sarsina (ITALY) Homeopathy, Homotoxicology, Integrative Medicine, Health Policy
Philippe Roch (FRANCE) Antimicrobial peptides and Comparative Immunology
Antonio Salatino (BRAZIL) Medicinal Plants and Propolis
Andrea Scheve (USA) Music Therapy
Shoji Shimizu (JAPAN) Immunology
Heung Muk Shin (KOREA) Korean Medicine
Kalyana Sundram (MALAYSIA) Antioxidants
Nobutaka Suzuki (JAPAN) Complementary and Alternative Medicine; Obstetrics and Gynecology
G. P. Talwar (INDIA) Immunology; Reproductive Health
Michel Tournaire (FRANCE) Obstetrics and Gynecology
Yamini Bhusan Tripathi (India) Ayurveda, Biochemistry, Chronic Diseases and Herbal Drugs
Jennie C.I.Tsao (USA) Biopsychosocial models of pain, inter-relationships between anxiety and pain
Yoshitaka Tsubono (JAPAN) Clinical Epidemiology
Gerhard Uhlenbruck (GERMANY) Complementary Medicine
Halmurat Upru (CHINA) Uighur Chinese Traditional Medicine
Taras Usichenko (GERMANY) Acupuncture and Pain Management
Carlo Ventura (ITALY) Molecular Biology, Stem Cell Engineering and Functional Genomics
Marja Verhoef (CANADA) Complementary Medicine
Aristo Vojdani (USA) Immunology
Haruhisa Wago (JAPAN) Immunobiology, Music Therapy
Peter White (U.K.) Acupuncture
Zhu-Fan Xie (CHINA) Integrated Chinese and Western Medicine
Haruki Yamada (JAPAN) Kampo Medicine
Baofeng Yang (CHINA) Pharmacology and Hypertension
Chae Ha Yang (KOREA) Acupuncture, Herbal Medicine and Drug Abuse
Gloria Y. Yeh (USA) Cardiovascular disease, diabetes, mind-body movement therapy
Dilxat Ymit (CHINA) Medical Microbiology, Immunology
Lonnie Zeltzer (USA) Pediatrics, Pediatric Pain
| 
刊名字顺( Alphabetical List of Journals):
返回页首 